サンプル依頼リスト カート
  • English
  • Korean
表紙：抗菌薬市場：製品タイプ別、投与経路別、流通別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
市場調査レポート
商品コード
1364699

抗菌薬市場：製品タイプ別、投与経路別、流通別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Antimicrobials Market, By Product Type, By Route of Administration, By Distribution, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 281 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
抗菌薬市場：製品タイプ別、投与経路別、流通別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年10月01日
発行: AnalystView Market Insights
ページ情報: 英文 281 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

抗菌剤市場規模は2022年に401億2,080万米ドルとなり、2023年から2030年にかけてCAGR 6.31%で拡大

抗菌薬市場- 市場力学

細菌感染症の増加が抗菌薬市場の成長を促進すると予想されます。

抗菌剤の使用は、細菌感染患者の治療に不可欠です。細菌感染症の負担に関する世界の包括的推計によると、2019年には世界で770万人が細菌性疾患により死亡しています。これは全世界の死亡者数の8分の1に相当します。また、細菌感染症は虚血性心疾患に次ぐ世界第2位の死因に昇格しています。細菌感染症は長い間、世界の健康負担の原因として過小評価されており、その緩和方法の緊急な増加が必要となっています。また、細菌感染症は、軽微な呼吸器感染症から敗血症のような致命的な病気まで様々です。

罹患者数の増加に伴い、これらの病気を治療しコントロールするための抗菌薬の需要も増加しています。世界保健機関（WHO）によると、最近の科学的発表によると、2017年には全世界で4,890万人の患者と1,100万人の敗血症関連死が発生し、全世界の死亡者数のほぼ20％を占めたと推定されています。さらに、バイオテクノロジーと製薬分野の革新は、新規抗菌薬と診断ツールの改良のための成長機会を提供する可能性があります。しかし、低所得国におけるインフラの欠如は、市場の成長を妨げる可能性があります。

抗菌薬市場-セグメンテーション分析：

抗菌剤の世界市場は、製品タイプ、用途、技術、地域に基づいてセグメント化されます。

市場は製品タイプによって3つのカテゴリーに分けられる：防腐剤、抗生物質、抗ウイルス剤、抗真菌剤、抗寄生虫剤です。抗生物質分野が市場を独占しているのは、ヒトに細菌感染が広く蔓延しているためです。抗生物質は、細菌感染の予防と治療に使用される医薬品です。抗菌薬耐性は、寄生虫（マラリアなど）、ウイルス（HIVなど）、真菌（カンジダなど）など、他の微生物による感染症を治療する薬に対する耐性を含む、より広い用語です。

市場は投与経路によって2つのカテゴリーに分けられる：経口薬、熱帯薬、非経口薬、その他です。抗菌薬の投与経路は、これらの薬剤がどのように体内に投与されるかを左右する重要な役割を担っており、その結果、有効性や使用の利便性が左右されます。投与経路は、使用する抗菌薬、治療する感染症、患者の状態などの要因によって決定されます。

市場は流通経路によって2つのカテゴリーに分けられる：クリニック、病院、その他。病院部門が市場を独占しています。病院薬剤師は伝統的に、制限薬の事前承認や処方医への監査とフィードバックの提供など、医薬品のガバナンスにおける責任を担ってきました。また、入院患者の様々な需要に対応するため、幅広い抗菌薬を常備しています。

抗菌薬市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。北米は、ヘルスケアインフラへの投資の増加により、抗菌薬市場の成長を支配すると予測されています。特に米国は、一人当たりのヘルスケア支出で常に上位にランクされています。この高水準の支出は、ヘルスケア・インフラへの投資だけでなく、医療研究、革新的な治療法、医薬品の進歩に対する同国の献身を示すものでもあります。米国の医療費は2021年に2.7％増の4兆3,000億米ドル、1人当たり1万2,914米ドルとなっています。この成長率は2020年（10.3％）より大幅に低いです。この支出の大幅な減速は、パンデミック関連の政府支出の減少が、治療の遅れや2020年からの需要の高まりにより回復した医療品やサービスの利用増を相殺したためと考えられる（米国医師会）。欧州は抗菌薬市場の成長において2番目に大きな地域であり、これは公的機関および民間機関による研究開発への投資が増加しているためです。

抗菌薬市場-競合情勢：

多剤耐性細菌病原体の世界の蔓延によって引き起こされる生命を脅かす感染症を治療するための新規抗菌薬の開発に対する現在の投資水準は、特に天然物由来および合成低分子の分野で増え続ける抗菌薬需要とは対照的です。このフェーズでは、メーカーは新しい抗生物質を特定し開発する能力を大幅に向上させるための戦略的計画を提供します。彼らは、学術、産業、政治の利害関係者間のギャップを埋め、次世代のためのトランスレーショナル・パイプラインを効率的に促進するために学際的な専門知識を結集することを目的として、研究と資金調達の様々な分野における最も差し迫った制限を克服するための短期的および長期的な解決策を提案します。さらに、大手製薬会社は抗菌薬市場において重要な役割を果たしています。彼らは、新規抗生物質、抗真菌薬、抗ウイルス薬、抗寄生虫薬の発見と製造のための研究開発に多額の投資を行っています。ファイザー、メルク、ジョンソン・エンド・ジョンソン、ノバルティスなどがその例です。

目次

第1章 抗菌薬市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 抗菌薬の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 抗菌剤産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 抗菌薬市場：COVID-19症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 抗菌薬市場情勢

  • 抗菌薬市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 抗菌薬市場-製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • 防腐剤
    • 抗生物質
    • 抗ウイルス薬
    • 抗真菌薬
    • 駆虫薬

第8章 抗菌薬市場- 投与経路別

  • 概要
    • 投与経路別セグメントシェア分析
    • オーラル
    • 話題
    • 非経口
    • その他

第9章 抗菌薬市場- 流通別

  • 概要
    • セグメントシェア分析（分布別）
    • 診療所
    • 病院
    • その他

第10章 抗菌薬市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 抗菌剤業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Abbott
    • AstraZeneca
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • Merck &Co.Inc.,
    • F. Hoffmann-La Roche Ltd
    • GlaxoSmithKline plc,
    • Mylan NV
    • Aurobindo Pharma
    • Cipla Inc.
    • Sun Pharmaceutical Industries Ltd
    • Amneal Pharmaceuticals LLC
    • Alembic Pharmaceuticals Limited
    • Lupin, Novartis AG
    • Zydus Cadila
    • Bausch Health Companies Inc.
    • Johnson &Johnson Private Limited
    • Dr. Reddy's Laboratories Ltd.
    • AbbVie Inc

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Antimicrobials Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Antimicrobials Market, by Product Type 2018-2030 (USD Million)
  • TABLE Antimicrobials Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Antimicrobials Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE Antimicrobials Market: Distribution Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution
  • TABLE Global Antimicrobials Market, by Distribution 2018-2030 (USD Million)
  • TABLE Antimicrobials Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Antimicrobials Market, by Region 2018-2030 (USD Million)
  • TABLE North America Antimicrobials Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Antimicrobials Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Antimicrobials Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE North America Antimicrobials Market, by Distribution, 2018-2030 (USD Million)
  • TABLE Europe Antimicrobials Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Antimicrobials Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Antimicrobials Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Antimicrobials Market, by Distribution, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antimicrobials Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antimicrobials Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antimicrobials Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antimicrobials Market, by Distribution, 2018-2030 (USD Million)
  • TABLE Latin America Antimicrobials Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Antimicrobials Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Antimicrobials Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Antimicrobials Market, by Distribution, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antimicrobials Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antimicrobials Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antimicrobials Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antimicrobials Market, by Distribution, 2018-2030 (USD Million)

List of Figures

  • FIGURE Antimicrobials Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Route of Administration segment market share analysis, 2022 & 2030
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Distribution segment market share analysis, 2022 & 2030
  • FIGURE Distribution segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Antimicrobials Market share and leading players, 2022
  • FIGURE Europe Antimicrobials Market share and leading players, 2022
  • FIGURE Asia Pacific Antimicrobials Market share and leading players, 2022
  • FIGURE Latin America Antimicrobials Market share and leading players, 2022
  • FIGURE Middle East and Africa Antimicrobials Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Antimicrobials Market share analysis by country, 2022
  • FIGURE Germany Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Antimicrobials Market share analysis by country, 2022
  • FIGURE India Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Antimicrobials Market share analysis by country, 2022
  • FIGURE Brazil Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Antimicrobials Market share analysis by country, 2022
  • FIGURE Saudi Arabia Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Antimicrobials Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1755

REPORT HIGHLIGHT

Antimicrobials Market size was valued at USD 40,120.8 Million in 2022, expanding at a CAGR of 6.31% from 2023 to 2030.

Antimicrobials are destroying or inhibiting the growth of microorganisms, especially pathogenic microorganisms. It is one of the most successful types of chemotherapy and has been used to protect the human population against infectious diseases. Many antimicrobials in general use are real antibiotics, having been identified from bacteria and fungi, but others are not. for example, The Environmental Protection Agency (EPA) in the United States regulates antimicrobial products as pesticides, while the Food and Drug Administration (FDA) in the United States regulates antimicrobial products as drugs/antiseptics. Antimicrobial products are used as pesticides on objects such as surfaces, toys, grocery carts, and hospital equipment. Antimicrobial products are used as antiseptics to treat or prevent diseases in humans, pets, and other living things.

Antimicrobials Market- Market Dynamics

An increase in the prevalence of bacterial infections is expected to drive Antimicrobials market growth.

The use of antibacterial agents is essential in the treatment of patients with bacterial infections. According to global comprehensive estimates of the burden of bacterial infections, 7.7 million deaths worldwide were due to bacterial illnesses in 2019. This equates to one-eighth of all global deaths. It also elevates bacterial infections to the world's second leading cause of death, trailing only ischemic heart disease. Bacterial infections have long been an underappreciated cause of global health burden, necessitating an urgent increase in mitigation methods. Also, bacterial infections can range from minor respiratory infections to potentially fatal illnesses such as sepsis.

As the number of persons afflicted grows, so does the demand for antimicrobial medications to treat and control these illnesses. According to the World Health Organization, a recent scientific publication estimated that in 2017 there were 48.9 million cases and 11 million sepsis-related deaths worldwide, which accounted for almost 20% of all global deaths. Furthermore, Innovations in the biotechnology and pharmaceutical sectors may provide a growing opportunity for novel antimicrobials and improved diagnostic tools, However, a lack of infrastructure in low-income countries may hamper the growth of the market.

Antimicrobials Market- Key Insights

  • As per the analysis shared by our research analyst, the global Antimicrobials market is estimated to grow annually at a CAGR of around 6.31% over the forecast period (2023-2030)
  • The antimicrobials market is expected to grow rapidly due to increased R&D efforts and well-established healthcare infrastructure.
  • Based on product type segmentation, Antibiotics was predicted to show maximum market share in the year 2022
  • Based on route of administration segmentation, Hospital sector was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Antimicrobials Market- Segmentation Analysis:

The Global Antimicrobials Market is segmented on the basis of Product Type, Application, Technology, and Region.

The market is divided into three categories based on product type: Antiseptics, Antibiotics, Antivirals, Antifungals and Antiparasitics. Antibiotics segment dominates the market, due to The widespread prevalence of bacterial infections in humans. Antibiotics are medicines used to prevent and treat bacterial infections. Antimicrobial resistance is a broader term, encompassing resistance to drugs to treat infections caused by other microbes as well, such as parasites (e.g. malaria), viruses (e.g. HIV) and fungi (e.g. Candida).

The market is divided into two categories based on Route of Administration: Oral, Tropical, Parenteral and others. Antimicrobial drug administration routes play an important role in influencing how these drugs are given to the body and, as a result, their effectiveness and convenience of usage. The route taken is determined by factors such as the antimicrobial used, the infection being treated, and the patient's state.

The market is divided into two categories based Distribution channel: Clinic, Hospital and others. Hospital sector dominate the market. Hospital pharmacists have traditionally assumed responsibilities in the governance of medications such as prior authorization for restricted drugs and provision of audit and feedback to prescribing physicians. Also, they have a wide range of antimicrobials on hand to meet the different demands of hospitalized patients.

Antimicrobials Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is projected to dominate the growth of the Antimicrobials market, due to Increasing investment in healthcare infrastructure. The United States, in particular, constantly ranks among the top countries in terms of healthcare expenditure per capita. This high level of spending shows not only investments in healthcare infrastructure, but also the country's dedication to medical research, innovative therapies, and pharmaceutical advancements. Health spending in the U.S. increased by 2.7% in 2021 to USD 4.3 trillion or USD 12,914 per capita. This growth rate is substantially lower than in 2020 (10.3% percent). This substantial deceleration in spending can be attributed to the decline in pandemic-related government expenditures offsetting increased utilization of medical goods and services that rebounded due to delayed care and pent-up demand from 2020, American Medical Association. Europe is the second largest region for the growth of the antimicrobials market, owing to rising in the investment for R&D by public and private organizations.

Antimicrobials Market- Competitive Landscape:

The current level of investment in the development of novel antimicrobials to treat life-threatening infections caused by the global spread of multidrug-resistant bacterial pathogens stands in stark contrast to the ever-increasing demand for them, particularly in the fields of natural-product-derived and synthetic small molecules. In this phase, manufacturers provide a strategic plan to significantly improve their ability to identify and develop new antibiotics. They propose both short-term and long-term solutions to overcome the most pressing limitations in various sectors of research and funding, with the goal of bridging the gap between academic, industrial, and political stakeholders and uniting interdisciplinary expertise in order to efficiently fuel the translational pipeline for future generations. Furthermore, Large pharmaceutical corporations play an important role in the antimicrobials market. They invest substantially in research & development to discover and manufacture novel antibiotics, antifungals, antivirals, and Antiparasitics medications. Pfizer, Merck, Johnson & Johnson, and Novartis are some examples.

Recent Developments:

In October 5, 2023, Merck is Collaborating to Address Antimicrobial Resistance

Antibiotics have transformed health care and saved countless lives. But rising levels of antimicrobial resistance (AMR) can make current antibiotics less effective. There's no simple solution to the complex problem of AMR, but Merck are committed to investing its expertise and resources alongside their partners to get antibiotics to those who need them most. Lives are at risk, and the time to act is now.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTIMICROBIALS MARKET KEY PLAYERS

  • Abbott, AstraZeneca
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Merck & Co.Inc.,
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc,
  • Mylan N.V.
  • Aurobindo Pharma
  • Cipla Inc.
  • Sun Pharmaceutical Industries Ltd
  • Amneal Pharmaceuticals LLC
  • Alembic Pharmaceuticals Limited
  • Lupin, Novartis AG
  • Zydus Cadila
  • Bausch Health Companies Inc.
  • Johnson & Johnson Private Limited
  • Dr. Reddy's Laboratories Ltd.
  • AbbVie Inc.,

GLOBAL ANTIMICROBIALS MARKET, BY PRODUCT TYPE

  • Antiseptics
  • Antibiotics
  • Antivirals
  • Antifungals
  • Antiparasitics

GLOBAL ANTIMICROBIALS MARKET, BY ROUTE OF ADMINISTRATION

  • Oral
  • Topical
  • Parenteral
  • Others

GLOBAL ANTIMICROBIALS MARKET, BY DISTRIBUTION

  • Clinic
  • Hospital
  • Others

GLOBAL ANTIMICROBIALS MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Antimicrobials Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Antimicrobials Market Snippet by Product Type
    • 2.1.2. Antimicrobials Market Snippet by Route of Administration
    • 2.1.3. Antimicrobials Market Snippet by Distribution
    • 2.1.4. Antimicrobials Market Snippet by Country
    • 2.1.5. Antimicrobials Market Snippet by Region
  • 2.2. Competitive Insights

3. Antimicrobials Key Market Trends

  • 3.1. Antimicrobials Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Antimicrobials Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Antimicrobials Market Opportunities
  • 3.4. Antimicrobials Market Future Trends

4. Antimicrobials Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Antimicrobials Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Antimicrobials Market Landscape

  • 6.1. Antimicrobials Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Antimicrobials Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Antiseptics
    • 7.1.3. Antibiotics
    • 7.1.4. Antivirals
    • 7.1.5. Antifungals
    • 7.1.6. Antiparasitics

8. Antimicrobials Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 8.1.2. Oral
    • 8.1.3. Topical
    • 8.1.4. Parenteral
    • 8.1.5. Others

9. Antimicrobials Market - By Distribution

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution, 2022 & 2030 (%)
    • 9.1.2. Clinic
    • 9.1.3. Hospital
    • 9.1.4. Others

10. Antimicrobials Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Antimicrobials Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Antimicrobials Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Antimicrobials Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Antimicrobials Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Antimicrobials Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Antimicrobials Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Abbott
    • 11.2.2. AstraZeneca
    • 11.2.3. Bristol-Myers Squibb Company
    • 11.2.4. Eli Lilly and Company
    • 11.2.5. Merck & Co.Inc.,
    • 11.2.6. F. Hoffmann-La Roche Ltd
    • 11.2.7. GlaxoSmithKline plc,
    • 11.2.8. Mylan N.V.
    • 11.2.9. Aurobindo Pharma
    • 11.2.10. Cipla Inc.
    • 11.2.11. Sun Pharmaceutical Industries Ltd
    • 11.2.12. Amneal Pharmaceuticals LLC
    • 11.2.13. Alembic Pharmaceuticals Limited
    • 11.2.14. Lupin, Novartis AG
    • 11.2.15. Zydus Cadila
    • 11.2.16. Bausch Health Companies Inc.
    • 11.2.17. Johnson & Johnson Private Limited
    • 11.2.18. Dr. Reddy's Laboratories Ltd.
    • 11.2.19. AbbVie Inc

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us